Last updated on April 2015

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma


Brief description of study

This randomised, controlled, multicentre trial is designed to assess the efficacy and safety of sequential icotinib plus chemotherapy versus single icotinib as first-line treatment in stage IIIB/IV lung adenocarcinoma patients with EGFR mutation.

Clinical Study Identifier: NCT02103257

Contact Investigators or Research Sites near you

Start Over

Helong Zhang, MD

First Hospital of Lanzhou University
Lanzhou, China
  Connect »

Helong Zhang, MD

Lanzhou military region general hospital
Lanzhou, China
  Connect »

Helong Zhang, MD

General Hospital of Guangzhou Military Command
Guangzhou, China
  Connect »

Helong Zhang, MD

Cancer Hospital of Sun Yat-sen
Guangzhou, China
  Connect »

Helong Zhang, MD

First Affiliated Hospital of Guangzhou Medical College
Guangzhou, China
  Connect »

Helong Zhang, MD

Jiangmen central hospital
Jiangmen, China
  Connect »

Helong Zhang, MD

The university of Hong Kong-Shenzhen Hospital
Shenzhen, China
  Connect »

Helong Zhang, MD

Shenzhen People's Hospital
Shenzhen, China
  Connect »

Helong Zhang, MD

Medical Oncology,Shenzhen Second People's Hospital
Shenzhen, China
  Connect »

Helong Zhang, MD

Thoracic Surgery,Shenzhen Second People's Hospital
Shenzhen, China
  Connect »

Helong Zhang, MD

Peking University Shenzhen Hospital
Shenzhen, China
  Connect »

Helong Zhang, MD

Guangdong Agribusiness Center Hospital
Zhanjiang, China
  Connect »

Helong Zhang, MD

First Affiliated Hospital of Guangxi Medical University
Nanning, China
  Connect »

Helong Zhang, MD

Hainan Provincal Nong Ken Hospital
Haikou, China
  Connect »

Helong Zhang, MD

Hainan Provincial People's Hospital
Haikou, China
  Connect »

Helong Zhang, MD

First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
  Connect »

Helong Zhang, MD

Medical Oncology General Hospital of Ningxia Medical University
Yinchuan, China
  Connect »

Helong Zhang, MD

Radiation Oncology General Hospital of Ningxia Medical University
Yinchuan, China
  Connect »

Helong Zhang, MD

Respiratory medicine General Hospital of Ningxia Medical University
Yinchuan, China
  Connect »

Helong Zhang, MD

Baoji Central Hospital
Baoji, China
  Connect »

Helong Zhang, MD

3201 Hospital, Hanzhong, Shanxi
Hanzhong, China
  Connect »

Helong Zhang, MD

Shaanxi province people's hospital
Xi'an, China
  Connect »

Helong Zhang, MD

Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
  Connect »

Helong Zhang, MD

Xi'an Chang'an Hospital
Xi'an, China
  Connect »

Helong Zhang, MD

Tangdu Hospital Fourth Military Medical University
Xi'an, China
  Connect »

Helong Zhang, MD

First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
  Connect »

Helong Zhang, MD

Shanxi Cancer Hospital
Xi'an, China
  Connect »

Helong Zhang, MD

Urumqi General Hospital of Lanzhou Military Region General Hospital
Urumqi, China
  Connect »

Helong Zhang, MD

Xinjiang medical university affiliated tumor hospital
Urumqi, China
  Connect »

Helong Zhang, MD

First Affiliated Hospital of Xinjiang Medical University
Urumqi, China
  Connect »

Helong Zhang, MD

Autonome Region Xinjiang Uygur Chinese medicine hospital
Urumqi, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.